Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.63B | $5.78B | $5.35B | $5.35B | $5.27B | $5.22B | $4.89B | — |
| Gross profit | $5.63B | $5.78B | $5.35B | $5.35B | $5.27B | $5.22B | $4.89B | — |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — |
| Research and development | $0 | $0 | $0 | — | $0 | $0 | $0 | $3.11M |
| Selling, general and administrative | $2.23B | $2.17B | $2.22B | $2.20B | $2.16B | $2.12B | $2.09B | $1.51M |
| Operating expenses | $4.23B | $4.54B | $4.76B | $4.46B | $4.47B | $4.36B | $7.25B | $4.62M |
| Operating income | $1.40B | $1.24B | $590.00M | $889.00M | $800.00M | $865.00M | −$2.36B | −$4.62M |
| Operating margin | 24.9% | 21.5% | 11.0% | 16.6% | 15.2% | 16.6% | -48.1% | — |
| EBITDA | $1.24B | $1.52B | $915.00M | $1.12B | $1.06B | $1.11B | −$2.12B | −$4.62M |
| Interest income | $0 | $0 | $0 | — | $0 | $0 | $0 | $665.00K |
| Interest expense | −$204.00M | −$205.00M | −$205.00M | −$206.00M | −$206.00M | −$204.00M | −$203.00M | −$7.00K |
| Income before taxes | $1.34B | $1.13B | $681.00M | $712.00M | $642.00M | $765.00M | $655.00M | −$3.96M |
| Income taxes | $295.00M | $226.00M | $37.00M | $133.00M | $120.00M | $143.00M | $83.00M | — |
| Net income | $1.05B | $906.00M | $644.00M | $579.00M | $522.00M | $622.00M | $572.00M | −$3.96M |
| Net margin | 18.6% | 15.7% | 12.0% | 10.8% | 9.9% | 11.9% | 11.7% | — |
| EPS, basic | $9.89 | $8.09 | $4.25 | $3.89 | $3.16 | $4.31 | $3.34 | −$0.19 |
| EPS, diluted | $9.84 | $8.01 | $4.22 | $3.86 | $3.14 | $4.27 | $3.32 | −$0.19 |
| Diluted shares | 83.96M | 87.60M | 87.91M | 88.61M | 91.79M | 95.02M | 95.83M | 21.16M |
Figures describe Tenet Healthcare shares, not any token. As of Jul 29, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.